NCT06669897 Validation of a Questionnaire to Measure Cough Severity
| NCT ID | NCT06669897 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
| Condition | Cough |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-05-01 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To design and validate a questionnaire that allows objective assessment of the severity of chronic cough
Eligibility Criteria
Inclusion Criteria: * Aged between 30 and 99 years * Clinical diagnosis of chronic cough or healthy volunteers * Good understanding of Spanish Exclusion Criteria: * Non-Spanish-speaking patients * Inability to complete the questionnaires * Failure to sign the informed consent form
Contact & Investigator
Astrid Crespo-Lessmann, PhD
PRINCIPAL INVESTIGATOR
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Frequently Asked Questions
Who can join the NCT06669897 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 99 Years, studying Cough. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06669897 currently recruiting?
Yes, NCT06669897 is actively recruiting participants. Contact the research team at acrespo@santpau.cat for enrollment information.
Where is the NCT06669897 trial being conducted?
This trial is being conducted at Badalona, Spain, L'Hospitalet de Llobregat, Spain, Sabadell, Spain, Barcelona, Spain and 2 additional locations.
Who is sponsoring the NCT06669897 clinical trial?
NCT06669897 is sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. The principal investigator is Astrid Crespo-Lessmann, PhD at Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. The trial plans to enroll 100 participants.